Tara Karamlou1, Karl F Welke2, D Michael McMullan2, Gordon A Cohen3, Jill Gelow4, Frederick A Tibayan5, James M Mudd4, Matthew S Slater5, Howard K Song5. 1. Division of Pediatric Cardiothoracic Surgery, Benioff Children's Hospital, University of California, San Francisco, San Francisco, Calif. Electronic address: tara.karamlou@ucsfmedctr.org. 2. Congenital Cardiac Center, Department of Pediatric Cardiac Surgery, Seattle Children's Hospital, Seattle, Wash. 3. Division of Pediatric Cardiothoracic Surgery, Benioff Children's Hospital, University of California, San Francisco, San Francisco, Calif. 4. Division of Cardiovascular Medicine, Oregon Health & Science University, Portland, Ore. 5. Division of Cardiothoracic Surgery, Oregon Health & Science University, Portland, Ore.
Abstract
OBJECTIVE: Criteria for simultaneous heart-kidney transplant (HKTx) recipients are unclear. We characterized the evolution of combined HKTx in the United States over time compared with isolated heart transplantation (HTx) and determined factors maximizing post-transplant survival. We focused on whether a threshold estimated glomerular filtration rate (eGFR) could be identified that justified combined transplantation. METHODS: A supplemented United Network Organ Sharing Dataset identified HTx and HKTx recipients from 2000 to 2010. eGFR was calculated for HTx and recipients were grouped into eGFR quintiles. Time-related mortality was compared among recipients, with multivariable factors sought using Cox proportional hazard regression models. RESULTS: We identified 26,183 HTx recipients, of whom 593 were HKTx recipients. HTx increased modestly over time (3.6%), whereas prevalence of HKTx increased dramatically (147%). Risk-unadjusted survival was similar among HTx recipients (8.4 ± 0.04 years) and HKTx recipients (7.7 ± 0.2 years) (P = .76). Isolated HTx recipients in the lowest eGFR quintile had decreased survival (P < .001), but those in the third eGFR quintile had superior survival, suggesting a benefit in this subgroup. HTx recipients in the lowest eGFR quintile (eGFR less than mean 37 mL/minute) had worse survival than combined HKTx recipients (7.1 ± 0.07 vs 7.7 ± 0.2; P < .001). Multivariable factors for increased mortality among HTx recipients included lower eGFR, higher recent panel reactive antibody score, older age, African American race, diabetes, longer ischemic time, and certain diagnoses. CONCLUSIONS: Performance of combined HKTx is increasing out of proportion to isolated HTx. eGFR is an important determinant of improved HTx survival. Combined HKTx recovers post-transplant survival in patients with eGFR <37 mL/minute and can be recommended in this subgroup.
OBJECTIVE: Criteria for simultaneous heart-kidney transplant (HKTx) recipients are unclear. We characterized the evolution of combined HKTx in the United States over time compared with isolated heart transplantation (HTx) and determined factors maximizing post-transplant survival. We focused on whether a threshold estimated glomerular filtration rate (eGFR) could be identified that justified combined transplantation. METHODS: A supplemented United Network Organ Sharing Dataset identified HTx and HKTx recipients from 2000 to 2010. eGFR was calculated for HTx and recipients were grouped into eGFR quintiles. Time-related mortality was compared among recipients, with multivariable factors sought using Cox proportional hazard regression models. RESULTS: We identified 26,183 HTx recipients, of whom 593 were HKTx recipients. HTx increased modestly over time (3.6%), whereas prevalence of HKTx increased dramatically (147%). Risk-unadjusted survival was similar among HTx recipients (8.4 ± 0.04 years) and HKTx recipients (7.7 ± 0.2 years) (P = .76). Isolated HTx recipients in the lowest eGFR quintile had decreased survival (P < .001), but those in the third eGFR quintile had superior survival, suggesting a benefit in this subgroup. HTx recipients in the lowest eGFR quintile (eGFR less than mean 37 mL/minute) had worse survival than combined HKTx recipients (7.1 ± 0.07 vs 7.7 ± 0.2; P < .001). Multivariable factors for increased mortality among HTx recipients included lower eGFR, higher recent panel reactive antibody score, older age, African American race, diabetes, longer ischemic time, and certain diagnoses. CONCLUSIONS: Performance of combined HKTx is increasing out of proportion to isolated HTx. eGFR is an important determinant of improved HTx survival. Combined HKTx recovers post-transplant survival in patients with eGFR <37 mL/minute and can be recommended in this subgroup.
Authors: Samuel T Coffin; Dia R Waguespack; Nicholas A Haglund; Simon Maltais; Jamie P Dwyer; Mary E Keebler Journal: Cardiorenal Med Date: 2015-01-09 Impact factor: 2.041
Authors: Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang Journal: Br J Pharmacol Date: 2020-05-13 Impact factor: 8.739
Authors: Swati Choudhry; Vikas R Dharnidharka; Chesney D Castleberry; Charles W Goss; Kathleen E Simpson; Kenneth B Schechtman; Charles E Canter Journal: J Heart Lung Transplant Date: 2017-10-02 Impact factor: 10.247
Authors: Adetokunbo A Taiwo; Kiran K Khush; Margaret R Stedman; Yuanchao Zheng; Jane C Tan Journal: Clin Transplant Date: 2018-10-25 Impact factor: 2.863
Authors: Oliver K Jawitz; Marat Fudim; Vignesh Raman; Vanessa Blumer; Kadir Caliskan; Adam D DeVore; Robert J Mentz; Carmelo Milano; Osama Soliman; Joseph Rogers; Chetan B Patel Journal: Ann Thorac Surg Date: 2020-01-03 Impact factor: 4.330
Authors: Oliver Beetz; Juliane Thies; Murat Avsar; Gerrit Grannas; Clara A Weigle; Fabio Ius; Michael Winkler; Christoph Bara; Nicolas Richter; Jürgen Klempnauer; Gregor Warnecke; Axel Haverich Journal: BMC Nephrol Date: 2021-07-09 Impact factor: 2.388